idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
14.02.2025 10:01

Blood thinner side effects diminish over time

Press Contact: Margareta G. Kubista, tel. +46 705 30 19 80, email press@sahlgrenska.gu.se Communications Department
Schwedischer Forschungsrat - The Swedish Research Council

    Blood thinners prescribed after blood clots in leg or lung initially increase the risk of bleeding, especially in women and elderly. But over time, this risk decreases and gender and age differences fade, a University of Gothenburg study shows.

    The aim of the study, published in the Journal of Internal Medicine, was to investigate the increased risk of bleeding during treatment with anticoagulants after a blood clot in the leg or lung. While the treatment protects against further clots, it increases the risk of bleeding.

    The standard protocol is to prescribe blood thinners for at least 3–6 months, also called initial treatment. After this time, the physician needs to decide whether to continue the treatment, which is called extended treatment. This decision entails weighing the risk of new blood clots if treatment is discontinued against the risk of bleeding if it is continued.

    Common side effects of blood thinners include nosebleeds, blood in the urine, blood in the stools, and more frequent and larger bruises, all because the blood is not clotting as usual. The risk of bleeding is linked to the treatment itself, that is, a treatment-induced risk, as well as the patient's baseline risk, which is not always considered.

    Initially increased risk of bleeding

    Current knowledge in the field is mainly focused on the overall risk of bleeding, with older people being at greater risk. The extent of the treatment-induced bleeding risk in different groups and different treatment phases, on the other hand, has remained unknown.

    The researchers used Swedish registry data encompassing more than 36,000 patients undergoing treatment with blood thinners after a blood clot in the leg or lung paired with an equal number of sex- and age-matched controls who had not had a clot and were not being treated with blood thinners.

    During the first six months, 338 people (1.07 percent) in the patient group experienced bleeding compared to 103 people (0.29 percent) in the control group. The treatment-induced risk for women was higher than for men, and the oldest participants, aged 80 and above, were most at risk.

    Diminished risk in the long run

    During extended treatment, in the study from six months up to five years, the treatment-induced risk of larger bleeds was no longer associated with gender or older age. Overall, the treatment-induced risk decreased from just over 2 percent during initial treatment to 0.7 percent during extended treatment.

    One of the driving forces behind the study is Katarina Glise Sandblad, a researcher at Sahlgrenska Academy at the University of Gothenburg as well as an internal medicine specialist at Sahlgrenska University Hospital.

    "When I treat patients with blood clots, the decision whether to discontinue treatment after the initial phase or to continue with lifelong treatment can be difficult. This study shows that the share of the bleeding risk due to blood thinners is low during extended treatment and doesn't seem to increase with age. This is reassuring for both me and my patients," she says.


    Wissenschaftliche Ansprechpartner:

    Katarina Glise Sandblad, researcher affiliated with Sahlgrenska Academy at the University of Gothenburg and specialist physician at Sahlgrenska University Hospital, tel. +46 707 70 80 82, email katarina.glise.sandblad@vgregion.se


    Originalpublikation:

    Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls, https://doi.org/10.1111/joim.20067


    Bilder

    Katarina Glise Sandblad
    Katarina Glise Sandblad
    photo: Karin Lerjestedt


    Merkmale dieser Pressemitteilung:
    Journalisten
    Medizin
    überregional
    Forschungsergebnisse
    Englisch


     

    Katarina Glise Sandblad


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).